Source: ForImmediateRelease

Press Release: Schrodinger : Schrödinger Announces Cryo-EM Initiative

Travel & Tourism Industry release: NEW YORK, Feb. 1, 2018 /PRNewswire/ - Schrödinger, a world-leading provider of molecular simulations and drug discovery software solutions dedicated to revolutionizing drug discovery through advanced computational methods, today announced the launch of Schrödinger Cryo-EM Initiative (SCI) to develop breakthrough medicines leveraging cryo-electron microscopy (Cryo-EM) technology and Schrödinger's leading drug • Read More »The post Schrödinger Announces Cryo-EM Initiative appeared first on forimmediaterelease.net.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Ramy Farid's photo - President & CEO of Schrodinger

President & CEO

Ramy Farid

CEO Approval Rating

88/100

Schrodinger develops a chemical simulation software that offers drug design and molecular modeling solutions for pharmaceutical and biotechnology companies. Read more